- Home
- JBLU vs CLDX Comparison
JBLU vs CLDX Comparison
Compare JBLU & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- CLDX
- Stock Information
- Founded
- JBLU 1998
- CLDX N/A
- Country
- JBLU United States
- CLDX United States
- Employees
- JBLU N/A
- CLDX N/A
- Industry
- JBLU Air Freight/Delivery Services
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- JBLU Consumer Discretionary
- CLDX Health Care
- Exchange
- JBLU Nasdaq
- CLDX Nasdaq
- Market Cap
- JBLU 2.0B
- CLDX 1.6B
- IPO Year
- JBLU N/A
- CLDX 2008
- Fundamental
- Price
- JBLU $4.74
- CLDX $26.22
- Analyst Decision
- JBLU Sell
- CLDX Strong Buy
- Analyst Count
- JBLU 9
- CLDX 8
- Target Price
- JBLU $5.11
- CLDX $46.13
- AVG Volume (30 Days)
- JBLU 18.2M
- CLDX 1.1M
- Earning Date
- JBLU 10-28-2025
- CLDX 11-05-2025
- Dividend Yield
- JBLU N/A
- CLDX N/A
- EPS Growth
- JBLU N/A
- CLDX N/A
- EPS
- JBLU N/A
- CLDX N/A
- Revenue
- JBLU $9,138,000,000.00
- CLDX $5,790,000.00
- Revenue This Year
- JBLU N/A
- CLDX N/A
- Revenue Next Year
- JBLU $6.77
- CLDX N/A
- P/E Ratio
- JBLU N/A
- CLDX N/A
- Revenue Growth
- JBLU N/A
- CLDX N/A
- 52 Week Low
- JBLU $3.34
- CLDX $14.40
- 52 Week High
- JBLU $8.31
- CLDX $31.66
- Technical
- Relative Strength Index (RSI)
- JBLU 41.43
- CLDX 60.30
- Support Level
- JBLU $4.63
- CLDX $24.49
- Resistance Level
- JBLU $4.95
- CLDX $26.90
- Average True Range (ATR)
- JBLU 0.17
- CLDX 1.00
- MACD
- JBLU -0.04
- CLDX 0.07
- Stochastic Oscillator
- JBLU 17.45
- CLDX 79.27
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.